OptimizeRx (OPRX) Competitors $4.91 +0.16 (+3.37%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OPRX vs. TRMR, EGHT, IBEX, ACCD, SHAP, RGP, BTOC, RMNI, AHG, and HQIShould you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Tremor International (TRMR), 8X8 (EGHT), IBEX (IBEX), Accolade (ACCD), Spree Acquisition Corp. 1 (SHAP), Resources Connection (RGP), Armlogi (BTOC), Rimini Street (RMNI), Akso Health Group (AHG), and HireQuest (HQI). These companies are all part of the "business services" industry. OptimizeRx vs. Tremor International 8X8 IBEX Accolade Spree Acquisition Corp. 1 Resources Connection Armlogi Rimini Street Akso Health Group HireQuest Tremor International (NASDAQ:TRMR) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings, profitability and community ranking. Which has more risk and volatility, TRMR or OPRX? Tremor International has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Does the media favor TRMR or OPRX? In the previous week, OptimizeRx had 8 more articles in the media than Tremor International. MarketBeat recorded 8 mentions for OptimizeRx and 0 mentions for Tremor International. OptimizeRx's average media sentiment score of 0.98 beat Tremor International's score of 0.00 indicating that OptimizeRx is being referred to more favorably in the news media. Company Overall Sentiment Tremor International Neutral OptimizeRx Positive Is TRMR or OPRX more profitable? Tremor International has a net margin of -5.72% compared to OptimizeRx's net margin of -27.41%. Tremor International's return on equity of 3.11% beat OptimizeRx's return on equity.Company Net Margins Return on Equity Return on Assets Tremor International-5.72% 3.11% 1.89% OptimizeRx -27.41%-4.92%-3.41% Do analysts prefer TRMR or OPRX? OptimizeRx has a consensus price target of $9.71, suggesting a potential upside of 97.85%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Tremor International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tremor International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00OptimizeRx 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do institutionals & insiders have more ownership in TRMR or OPRX? 7.9% of Tremor International shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 8.2% of Tremor International shares are held by company insiders. Comparatively, 6.1% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor TRMR or OPRX? OptimizeRx received 127 more outperform votes than Tremor International when rated by MarketBeat users. Likewise, 63.60% of users gave OptimizeRx an outperform vote while only 58.14% of users gave Tremor International an outperform vote. CompanyUnderperformOutperformTremor InternationalOutperform Votes2558.14% Underperform Votes1841.86% OptimizeRxOutperform Votes15263.60% Underperform Votes8736.40% Which has higher valuation and earnings, TRMR or OPRX? Tremor International has higher revenue and earnings than OptimizeRx. Tremor International is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTremor International$343.77M2.07$22.74M-$0.14-70.07OptimizeRx$88.18M1.03-$17.57M-$1.33-3.69 SummaryTremor International and OptimizeRx tied by winning 9 of the 18 factors compared between the two stocks. Ad Paradigm Press Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPRX vs. The Competition Export to ExcelMetricOptimizeRxBusiness services IndustryComputer SectorNASDAQ ExchangeMarket Cap$87.50M$19.94B$25.75B$9.07BDividend YieldN/A2.58%2.78%4.22%P/E Ratio-3.6927.94241.6517.19Price / Sales1.0310.803,321.73116.80Price / CashN/A35.3435.7337.86Price / Book0.705.908.084.78Net Income-$17.57M$525.34M$678.74M$225.60M7 Day Performance-1.60%-0.65%0.42%-1.23%1 Month Performance9.35%-2.17%6.97%3.37%1 Year Performance-65.54%18.44%23.01%16.58% OptimizeRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPRXOptimizeRx4.034 of 5 stars$4.91+3.4%$9.71+97.8%-65.0%$87.50M$88.18M-3.69100Analyst ForecastNews CoverageTRMRTremor InternationalN/A$5.02+1.0%N/A+106.2%$364.54M$343.77M-73.57167EGHT8X82.1265 of 5 stars$2.63flat$2.79+5.9%-21.2%$343.64M$719.56M-4.781,948Analyst ForecastIBEXIBEX1.2644 of 5 stars$20.20+0.6%$21.25+5.2%+8.9%$338.65M$513.68M10.6230,000Insider TradeACCDAccolade4.9011 of 5 stars$3.57+2.3%$9.04+153.3%-67.8%$287.52M$441.03M-3.392,400Analyst ForecastSHAPSpree Acquisition Corp. 1N/A$10.91-0.2%N/AN/A$283.07MN/A0.00N/ANews CoverageRGPResources Connection4.356 of 5 stars$8.34-3.1%$13.00+55.9%-41.9%$279.14M$632.80M23.923,376Positive NewsBTOCArmlogi0.5941 of 5 stars$5.73+3.2%N/AN/A$238.56M$168.21M555.00N/ANews CoveragePositive NewsGap UpRMNIRimini Street3.0768 of 5 stars$2.59+31.5%$4.50+73.7%-21.3%$235.48M$431.50M-5.322,120Analyst UpgradePositive NewsHigh Trading VolumeAHGAkso Health Group0.4778 of 5 stars$1.49+54.4%N/A+73.2%$217.13M$2.41M0.0040Positive NewsGap DownHigh Trading VolumeHQIHireQuest3.6624 of 5 stars$14.74+0.6%$18.50+25.5%-11.1%$206.36M$36.28M133.1873,000News Coverage Related Companies and Tools Related Companies Tremor International Alternatives 8X8 Alternatives IBEX Alternatives Accolade Alternatives Spree Acquisition Corp. 1 Alternatives Resources Connection Alternatives Armlogi Alternatives Rimini Street Alternatives Akso Health Group Alternatives HireQuest Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OPRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.